LINC02140: A Potential Drug Target and Biomarker (G100996345)

Target Name: LINC02140

NCBI ID: G100996345

LINC02140

Other Name(s): long intergenic non-protein coding RNA 2140 | Long intergenic non-protein coding RNA 2140, transcript variant 1

LINC02140: A Potential Drug Target and Biomarker

LINC02140 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in the development, maintenance, and progression of various diseases, including cancer. LINC02140 has been shown to have a positive correlation with cancer outcomes, including tumor growth and metastasis.

The discovery of LINC02140 as a potential drug target and biomarker has significant implications for the development of new cancer therapies. By blocking the activity of LINC02140, researchers hope to inhibit the growth and spread of cancer cells and potentially lead to a more effective treatment of cancer.

In addition to its potential as a drug target, LINC02140 has also been identified as a potential biomarker for cancer. Its expression has been shown to be significantly increased in a variety of cancer types, including breast, ovarian, and colorectal cancers. This suggests that LINC02140 could be used as a diagnostic marker for cancer and could potentially be used in combination with other biomarkers to improve the accuracy of cancer diagnosis.

The study of LINC02140 as a potential drug target and biomarker is still in its early stages, but it has the potential to lead to a more effective and personalized approach to cancer treatment. As research continues to progress, scientists and doctors will be able to better understand the role of LINC02140 in cancer development and use this information to develop new and more effective therapies.

In conclusion, LINC02140 is a promising candidate as a drug target and biomarker for cancer. Further research is needed to fully understand its role in cancer development and to develop effective therapies that target it. However, the potential of LINC02140 as a drug and biomarker is significant and has the potential to lead to new and more effective treatments for cancer.

Protein Name: Long Intergenic Non-protein Coding RNA 2140

The "LINC02140 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02140 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets